Literature DB >> 23965549

Renal vasodilating capacity and endothelial function are impaired in patients with obstructive sleep apnea syndrome and no traditional cardiovascular risk factors.

Rosa M Bruno1, Leonardo Rossi, Monica Fabbrini, Emiliano Duranti, Elisa Di Coscio, Michelangelo Maestri, Patrizia Guidi, Giada Frenzilli, Alessandra Salvetti, Stefano Taddei, Enrica Bonanni, Lorenzo Ghiadoni.   

Abstract

OBJECTIVE: Patients with obstructive sleep apnea syndrome exhibit accelerated vascular aging and renal damage. Aim of the study was to investigate whether vascular dysfunction is a feature of obstructive sleep apnea syndrome per se or instead related to the presence of traditional cardiovascular risk factors.
METHODS: Forty patients with moderate-severe obstructive sleep apnea syndrome (20 with, 20 without traditional risk factors) and 20 matched healthy controls were enrolled. Renal vasodilating capacity, endothelium-dependent vasodilation in the brachial artery, carotid-femoral pulse wave velocity and carotid stiffness were measured. Oxidative stress, endothelial biomarkers and leukocyte adhesion molecule levels were also evaluated.
RESULTS: Apneic patients without traditional cardiovascular risk factors presented reduced endothelium-dependent vasodilation (3.7±2.1 versus 6.1±3.0%, P<0.05), increased serum E-selectin (49.8±11.5 versus 38.9±17.9 ng/ml, P<0.05), and impaired renal vasodilating capacity (6.0±4.3 versus 10.4±6.1%, P<0.05), as compared to healthy controls. Endothelial NO synthase expression was reduced (0.0133 versus 0.0221×10 copies/μg RNA, P<0.05), whereas oxidative stress parameters and leukocyte adhesion molecules were similar to controls. Patients with obstructive sleep apnea syndrome and traditional risk factors also exhibit increased aortic and carotid stiffness, increased renal resistive index and intima-media thickness, and reduced expression of the endothelial progenitor cell marker CD34: however, these parameters were similar to those of healthy controls in patients with isolated obstructive sleep apnea syndrome.
CONCLUSION: Obstructive sleep apnea syndrome is characterized by endothelial dysfunction and activation and impaired renal vasodilating capacity even in the absence of traditional cardiovascular risk factors, possibly due to reduced endothelial NO synthase expression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23965549     DOI: 10.1097/HJH.0b013e328360f773

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  18 in total

Review 1.  Emerging co-morbidities of obstructive sleep apnea: cognition, kidney disease, and cancer.

Authors:  Nadia Gildeh; Panagis Drakatos; Sean Higgins; Ivana Rosenzweig; Brian D Kent
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

2.  Intrarenal hemodynamic and oxidative stress in patients with obstructive sleep apnea syndrome.

Authors:  L Sardo; P Palange; F Di Mario; B Barbano; A Gigante; M Mordenti; A Steffanina; M Bonini; A Amoroso; F Vaccaro; R Cianci
Journal:  Sleep Breath       Date:  2015-04-01       Impact factor: 2.816

3.  Obstructive sleep apnea and chronic kidney disease: open questions on a potential public health problem.

Authors:  Oreste Marrone; Maria R Bonsignore
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

4.  Peripheral blood oxidative stress markers for obstructive sleep apnea-a meta-analysis.

Authors:  Yuzhui Hu; Lin Mai; Jingying Luo; Wensong Shi; Hui Xiang; Sijia Song; Liuyan Hong; Wenting Long; Biwen Mo; Miao Luo
Journal:  Sleep Breath       Date:  2022-01-03       Impact factor: 2.816

5.  Cumulative Hypoxemia During Sleep Predicts Vascular Endothelial Dysfunction in Patients With Sleep-Disordered Breathing.

Authors:  Hiroyuki Sawatari; Akiko Chishaki; Mari Nishizaka; Tomotake Tokunou; Sonomi Adachi; Chikara Yoshimura; Tomoko Ohkusa; Shin-ichi Ando
Journal:  Am J Hypertens       Date:  2015-08-18       Impact factor: 2.689

6.  Nocturnal pulse rate and symptomatic response in patients with obstructive sleep apnoea treated with continuous positive airway pressure for one year.

Authors:  Martino F Pengo; Panagis Drakatos; Christopher Kosky; Adrian Williams; Nicholas Hart; Gian Paolo Rossi; Joerg Steier
Journal:  J Thorac Dis       Date:  2014-06       Impact factor: 2.895

7.  Arterial stiffness alteration and obstructive sleep apnea in an elderly cohort free of cardiovascular event history: the PROOF cohort study.

Authors:  Emilia Sforza; Sandrine Millasseau; David Hupin; Jean-Claude Barthélémy; Frédéric Roche
Journal:  Sleep Breath       Date:  2018-06-26       Impact factor: 2.816

8.  Predictive value of dynamic renal resistive index (DRIN) for renal outcome in type 2 diabetes and essential hypertension: a prospective study.

Authors:  R M Bruno; A Salvati; M Barzacchi; K Raimo; S Taddei; L Ghiadoni; A Solini
Journal:  Cardiovasc Diabetol       Date:  2015-05-22       Impact factor: 9.951

9.  Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Patients with Obstructive Sleep Apnea.

Authors:  Manish R Maski; Robert J Thomas; S Ananth Karumanchi; Samir M Parikh
Journal:  PLoS One       Date:  2016-05-05       Impact factor: 3.240

10.  Effects of obstructive sleep apnea on the thoracic aorta and the main pulmonary artery: assessment by CT.

Authors:  Roberto Castellana; Giacomo Aringhieri; Luna Gargani; Michelangelo Maestri; Alessandro Schirru; Enrica Bonanni; Ugo Faraguna
Journal:  J Clin Sleep Med       Date:  2021-01-01       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.